share_log

JMP Securities Reiterates Market Outperform on BioAtla, Maintains $12 Price Target

JMP Securities Reiterates Market Outperform on BioAtla, Maintains $12 Price Target

JMP Securities重申BioAtla的市场跑赢大盘,维持12美元的目标股价
Benzinga ·  2023/12/05 09:17

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

JMP Securities分析师雷尼·本杰明重申BioAtla(纳斯达克股票代码:BCAB)的股价跑赢大盘,维持12美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发